Crystal structure of -aconitate decarboxylase reveals the impact of naturally occurring human mutations on itaconate synthesis.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Iqbal, Azeem Ahmed
van den Heuvel, Joop
MetadataShow full item record
Abstractcis-Aconitate decarboxylase (CAD, also known as ACOD1 or Irg1) converts cis-aconitate to itaconate and plays central roles in linking innate immunity with metabolism and in the biotechnological production of itaconic acid by Aspergillus terreus We have elucidated the crystal structures of human and murine CADs and compared their enzymological properties to CAD from A. terreus Recombinant CAD is fully active in vitro without a cofactor. Murine CAD has the highest catalytic activity, whereas Aspergillus CAD is best adapted to a more acidic pH. CAD is not homologous to any known decarboxylase and appears to have evolved from prokaryotic enzymes that bind negatively charged substrates. CADs are homodimers, the active center is located in the interface between 2 distinct subdomains, and structural modeling revealed conservation in zebrafish and Aspergillus We identified 8 active-site residues critical for CAD function and rare naturally occurring human mutations in the active site that abolished CAD activity, as well as a variant (Asn152Ser) that increased CAD activity and is common (allele frequency 20%) in African ethnicity. These results open the way for 1) assessing the potential impact of human CAD variants on disease risk at the population level, 2) developing therapeutic interventions to modify CAD activity, and 3) improving CAD efficiency for biotechnological production of itaconic acid.
CitationProc Natl Acad Sci U S A. 2019 Sep 23. pii: 1908770116. doi:10.1073/pnas.1908770116.
AffiliationHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany; TWINCORE, Zentrum für experimentelle und klinische Infektionsforschung GmbH,Feodor-Lynen Str. 7, 30625 Hannover, Germany.
PublisherNational Academy of Sciences
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
- Ustilago maydis produces itaconic acid via the unusual intermediate trans-aconitate.
- Authors: Geiser E, Przybilla SK, Friedrich A, Buckel W, Wierckx N, Blank LM, Bölker M
- Issue date: 2016 Jan
- Heterologous expression of Mus musculus immunoresponsive gene 1 (irg1) in Escherichia coli results in itaconate production.
- Authors: Vuoristo KS, Mars AE, van Loon S, Orsi E, Eggink G, Sanders JP, Weusthuis RA
- Issue date: 2015
- Expression of the Aspergillus terreus itaconic acid biosynthesis cluster in Aspergillus niger.
- Authors: van der Straat L, Vernooij M, Lammers M, van den Berg W, Schonewille T, Cordewener J, van der Meer I, Koops A, de Graaff LH
- Issue date: 2014 Jan 17
- Improving itaconic acid production through genetic engineering of an industrial Aspergillus terreus strain.
- Authors: Huang X, Lu X, Li Y, Li X, Li JJ
- Issue date: 2014 Aug 11
- Enhanced itaconic acid production by self-assembly of two biosynthetic enzymes in Escherichia coli.
- Authors: Yang Z, Gao X, Xie H, Wang F, Ren Y, Wei D
- Issue date: 2017 Feb